Aoife C. Maxwell

2.7k total citations · 2 hit papers
32 papers, 2.2k citations indexed

About

Aoife C. Maxwell is a scholar working on Physiology, Organic Chemistry and Inorganic Chemistry. According to data from OpenAlex, Aoife C. Maxwell has authored 32 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 11 papers in Organic Chemistry and 11 papers in Inorganic Chemistry. Recurrent topics in Aoife C. Maxwell's work include Asthma and respiratory diseases (12 papers), Asymmetric Hydrogenation and Catalysis (11 papers) and Catalytic C–H Functionalization Methods (5 papers). Aoife C. Maxwell is often cited by papers focused on Asthma and respiratory diseases (12 papers), Asymmetric Hydrogenation and Catalysis (11 papers) and Catalytic C–H Functionalization Methods (5 papers). Aoife C. Maxwell collaborates with scholars based in United Kingdom, Italy and United States. Aoife C. Maxwell's co-authors include Andrew J. A. Watson, Jonathan M. J. Williams, Gareth W. Lamb, Malai Haniti S. A. Hamid, Hannah C. Maytum, C. Liana Allen, Stephen R. Durham, Shuaib Nasser, Marjolein Cornet and Valerie Lund and has published in prestigious journals such as Journal of the American Chemical Society, Scientific Reports and Journal of Allergy and Clinical Immunology.

In The Last Decade

Aoife C. Maxwell

29 papers receiving 2.1k citations

Hit Papers

Ruthenium-CatalyzedN-Alkylation of Amines and Sulfonamide... 2009 2026 2014 2020 2009 2017 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aoife C. Maxwell United Kingdom 17 1.3k 1.1k 600 433 310 32 2.2k
David E. Hill United States 15 442 0.3× 102 0.1× 491 0.8× 20 0.0× 9 0.0× 23 1.2k
Charles E. Hammond United States 18 318 0.2× 173 0.2× 233 0.4× 27 0.1× 34 0.1× 49 1.0k
Richard W. Ahn United States 18 282 0.2× 190 0.2× 474 0.8× 15 0.0× 46 0.1× 33 1.4k
Minghao Xu China 20 938 0.7× 67 0.1× 738 1.2× 134 0.3× 34 0.1× 40 1.5k
Masayuki Hasegawa Japan 18 572 0.4× 126 0.1× 425 0.7× 8 0.0× 10 0.0× 45 1.3k
André Egli Switzerland 15 429 0.3× 325 0.3× 319 0.5× 8 0.0× 27 0.1× 18 1.9k
K. Abiraj India 21 341 0.3× 138 0.1× 243 0.4× 6 0.0× 5 0.0× 77 1.2k
Yanan Han China 17 122 0.1× 162 0.1× 385 0.6× 9 0.0× 10 0.0× 45 925
Lourdes Cabrera United States 12 362 0.3× 245 0.2× 150 0.3× 9 0.0× 48 0.2× 35 951
Qingqing Zhang China 18 537 0.4× 123 0.1× 493 0.8× 10 0.0× 11 0.0× 59 1.3k

Countries citing papers authored by Aoife C. Maxwell

Since Specialization
Citations

This map shows the geographic impact of Aoife C. Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aoife C. Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aoife C. Maxwell more than expected).

Fields of papers citing papers by Aoife C. Maxwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aoife C. Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aoife C. Maxwell. The network helps show where Aoife C. Maxwell may publish in the future.

Co-authorship network of co-authors of Aoife C. Maxwell

This figure shows the co-authorship network connecting the top 25 collaborators of Aoife C. Maxwell. A scholar is included among the top collaborators of Aoife C. Maxwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aoife C. Maxwell. Aoife C. Maxwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chupp, Geoffrey, Liam G. Heaney, Girolamo Pelaia, et al.. (2025). Impact of Demographics on Mepolizumab Effectiveness in Severe Asthma: One-Year REALITI-A Subanalysis. The Journal of Allergy and Clinical Immunology In Practice. 13(12). 3286–3295.
2.
Lee, Jason K., S. Pollard, Mark C. Liu, et al.. (2025). Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma. Annals of Allergy Asthma & Immunology. 135(1). 37–46. 4 indexed citations
3.
Liu, Mark C., Diego Bagnasco, Andrea Matucci, et al.. (2023). Mepolizumab in Patients With Severe Asthma and Comorbidities: 1-Year REALITI-A Analysis. The Journal of Allergy and Clinical Immunology In Practice. 11(12). 3650–3661.e3. 19 indexed citations
4.
Hamy, Valentin, Christopher Yee, Luis Garcia‐Gancedo, et al.. (2023). Patient-centric assessment of rheumatoid arthritis using a smartwatch and bespoke mobile app in a clinical setting. Scientific Reports. 13(1). 18311–18311. 4 indexed citations
5.
Lee, Jason T., Mark Liu, Florence Schleich, et al.. (2023). Real-World Benefits of Mepolizumab in Patients With Overlapping Allergic and Eosinophilic Endophenotypes: Post Hoc Analysis of REALITI-A by Omalizumab Eligibility. Journal of Allergy and Clinical Immunology. 151(2). AB21–AB21. 1 indexed citations
6.
Pilette, Charles, Giorgio Walter Canonica, Rekha Chaudhuri, et al.. (2022). REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma. The Journal of Allergy and Clinical Immunology In Practice. 10(10). 2646–2656. 53 indexed citations
7.
Bernstein, David, Mark Liu, Florence Schleich, et al.. (2022). The Impact Of Baseline Exhaled Nitric Oxide Levels And Blood Eosinophil Count On Clinical Outcomes In REALITI-A. Journal of Allergy and Clinical Immunology. 149(2). AB189–AB189. 1 indexed citations
8.
Lee, Jason T., S. Pollard, Mark Liu, et al.. (2022). Influence of Baseline Total IgE and History of Previous Omalizumab Use on the Impact of Mepolizumab in Reducing Rate of Severe Asthma Exacerbations: Results From the Real-World REALITI-A Study. Journal of Allergy and Clinical Immunology. 149(2). AB191–AB191. 1 indexed citations
10.
Harrison, Tim, Giorgio Walter Canonica, Geoffrey Chupp, et al.. (2020). Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis. European Respiratory Journal. 56(4). 2000151–2000151. 91 indexed citations
11.
Bachert, Claus, Ana R. Sousa, Valerie Lund, et al.. (2017). Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial. Journal of Allergy and Clinical Immunology. 140(4). 1024–1031.e14. 352 indexed citations breakdown →
12.
Tajuddin, Hazmi, Ibraheem A. I. Mkhalid, Andrei S. Batsanov, et al.. (2014). Iridium-catalyzed C–H borylation of pyridines. Organic & Biomolecular Chemistry. 12(37). 7318–7318. 84 indexed citations
13.
Fray, M. Jonathan, Simon J. F. Macdonald, Jack A. Brown, et al.. (2013). A practical drug discovery project at the undergraduate level. Drug Discovery Today. 18(23-24). 1158–1172. 11 indexed citations
14.
Alder, Catherine M., Amanda Campbell, Angela M. Deakin, et al.. (2013). Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping Strategy. ACS Medicinal Chemistry Letters. 4(10). 948–952. 16 indexed citations
15.
Watson, Andrew J. A., Benjamin N. Atkinson, Aoife C. Maxwell, & Jonathan M. J. Williams. (2013). Ruthenium‐Catalyzed Remote Electronic Activation of Aromatic CF Bonds. Advanced Synthesis & Catalysis. 355(4). 734–740. 13 indexed citations
16.
Tajuddin, Hazmi, Bianca Bitterlich, J.C. Collings, et al.. (2012). Iridium-catalyzed C–H borylation of quinolines and unsymmetrical 1,2-disubstituted benzenes: insights into steric and electronic effects on selectivity. Chemical Science. 3(12). 3505–3505. 152 indexed citations
17.
Watson, Andrew J. A., Aoife C. Maxwell, & Jonathan M. J. Williams. (2011). Ruthenium-catalysed oxidative synthesis of heterocycles from alcohols. Organic & Biomolecular Chemistry. 10(2). 240–243. 136 indexed citations
18.
Maxwell, Aoife C., et al.. (2010). Rhodium-catalysed hydroboration employing new Quinazolinap ligands; an investigation into electronic effects. Tetrahedron Asymmetry. 21(11-12). 1458–1473. 20 indexed citations
19.
Watson, Andrew J. A., Aoife C. Maxwell, & Jonathan M. J. Williams. (2009). Ruthenium-Catalyzed Oxidation of Alcohols into Amides. Organic Letters. 11(12). 2667–2670. 229 indexed citations
20.
Maxwell, Aoife C., et al.. (2008). Electronically varied quinazolinaps for asymmetric catalysis. Organic & Biomolecular Chemistry. 6(20). 3848–3848. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026